Verastem Stock Price. Everything You Need To Know About The Verastem Stock!
Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company is headquartered in Cambridge, Massachusetts and currently employs 57 full-time employees. The company went IPO on 2011-11-08. The Company’s pipeline is focused on anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase kinase (MEK) inhibition and focal adhesion kinase (FAK) inhibition. The Company’s advanced product candidates, Avutometinib (VS-6766) and Defactinib, are being investigated in both preclinical and clinical studies for the treatment of various solid tumors, including, but not limited to low-grade serous ovarian cancer (LGSOC), non-small cell lung cancer (NSCLC), colorectal cancer (CRC), pancreatic cancer, and melanoma. VS-6766 is an orally available small molecule RAF/MEK clamp. Defactinib is an oral small molecule inhibitor of FAK and proline-rich tyrosine kinase (PYK2) that is being evaluated as a potential combination therapy for various solid tumors.
Verastem Stock Price. Everything You Need To Know About The Verastem Stock! performance
- Employees 57
- Company HQ Cambridge
- Website http://www.verastem.com/
- VSTM Asset Type Common Stock
- VSTM Market Capitalization 243.7M
- Earnings Per Share -3.96
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in the stock market? Look no further! Zorion, the leading investment platform, is here to provide you with all the information you need to make informed decisions. Today, we are discussing Verastem, a promising stock to consider. Verastem is an innovative biopharmaceutical company focused on developing treatments for cancer. With a strong portfolio of drugs and therapies in the pipeline, Verastem offers exciting investment opportunities for retail investors. But how can you invest in Verastem from Malaysia, Thailand, Indonesia, or Vietnam? Zorion provides a user-friendly platform that allows you to invest in real US stocks and pre-IPO companies. Through our investment insights and recommendations, you can stay updated on Verastem’s performance and make well-informed decisions. Moreover, Zorion offers a range of resources and educational materials to enhance your investment knowledge. Investing in Verastem from Malaysia, Thailand, Indonesia, or Vietnam has never been easier. Join Zorion today and start your investment journey towards a more prosperous future.
